Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify ...

While celebrities like Michael J. Fox and Brett Favre have been open about their struggles with Parkinson's disease, it can ...

Substantial progress has been made over the past four decades in treating the symptoms of Parkinson ... slow progression of Parkinson disease and delay its clinical emergence.

The Aligning Science Across Parkinson’s (ASAP) initiative opened applications for members of the research community to apply to join the Collaborative Research Network (CRN) 2025 Scientific Track. The ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the initial cognitive damage caused by dementia, and explains how it works ...

Acadia files regulatory application for trofinetide to treat Rett syndrome in EU. The company also outlines other pipeline goals for 2025-2026.

AskBio begins patient randomizing in phase II gene therapy trial for Parkinson’s disease: Berlin, Germany Wednesday, January 15, 2025, 14:00 Hrs [IST] AskBio Inc. (AskBio), a ge ...

Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. Research shows that the drug activates the cannabinoid ...

WHIPPANY, NJ, USA I January 14, 2025 I On the occasion of the 43rd J.P. Morgan Healthcare Conference in San Francisco, Bayer AG announces further progress in ...

Forty percent of high school students say they feel sad and hopeless, and 20% have seriously considered suicide. A chronic ...